• Accueil >
  • Publications >
  • Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology

Addressing heterogeneity in the design of phase II clinical trials in geriatric oncology

1 nov. 2018European Journal of Cancer

DOI : 10.1016/j.ejca.2018.07.136

Auteurs

Bastien Cabarrou, Patrick Sfumato, Loïc Mourey, Eve Leconte, Laurent Balardy, Alejandra Martinez, Jean-Pierre Delord, Jean-Marie Boher, Etienne Brain, Thomas Filleron